These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 22831842

  • 21. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S, Charra B, Hachimi A, Benslama A.
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract] [Full Text] [Related]

  • 22. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
    Jean SS, Hsieh TC, Lee WS, Hsueh PR, Hsu CW, Lam C.
    Medicine (Baltimore); 2018 Sep; 97(39):e12278. PubMed ID: 30278498
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V.
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
    Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D.
    Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
    [Abstract] [Full Text] [Related]

  • 29. In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
    Hornsey M, Phee L, Longshaw C, Wareham DW.
    Int J Antimicrob Agents; 2013 Mar; 41(3):285-7. PubMed ID: 23312607
    [Abstract] [Full Text] [Related]

  • 30. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B, Guan J, Wang X, Cong Y.
    PLoS One; 2016 Mar; 11(6):e0157757. PubMed ID: 27315107
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E, 309 Study Group.
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [Abstract] [Full Text] [Related]

  • 33. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ, Goff DA, Stevenson KB, Mangino JE.
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [Abstract] [Full Text] [Related]

  • 34. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
    Candel FJ, Calvo N, Head J, Sánchez A, Matesanz M, Culebras E, Barrientos A, Picazo J.
    Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
    [Abstract] [Full Text] [Related]

  • 35. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R, Dowzicky MJ.
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [Abstract] [Full Text] [Related]

  • 36. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y, Chai D, Wang R, Liang B, Bai N.
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS, Hsieh TC, Hsu CW, Lee WS, Bai KJ, Lam C.
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic options for Acinetobacter baumannii infections.
    Vila J, Pachón J.
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [Abstract] [Full Text] [Related]

  • 39. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X, Yang Z, Dai J, Chen K, Zhang L, Ni W, Wei C, Cui J.
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [Abstract] [Full Text] [Related]

  • 40. Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens.
    Jean SS, Hsueh PR.
    Expert Opin Pharmacother; 2011 Oct; 12(14):2145-8. PubMed ID: 21895553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.